Strata Critical Medical, Inc. Class A Common Stock (SRTA) Q1 2026 Earnings
Strata Critical Medical, Inc. Class A Common Stock reported Q1 2026 revenue of $67.4M (+24.1% YoY), beat analyst consensus of $63.7M by $3.7M. Diluted EPS came in at $0.03, beat the $-0.04 consensus by $0.07.
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Strata Critical Medical, Inc. Class A Common Stock's Q1 2026 earnings report.
Strata Critical Medical, Inc. Class A Common Stock (SRTA) reported Q1 2026 earnings on May 6, 2026 before market open.
Strata Critical Medical, Inc. Class A Common Stock reported revenue of $67.4M and diluted EPS of $0.03 for Q1 2026.
Revenue beat the consensus estimate of $63.7M by $3.7M. EPS beat the consensus estimate of $-0.04 by $0.07.
Compared to the same quarter a year prior, revenue grew 24.1% from $54.3M a year earlier.
You can read the 8-K earnings release (0001628280-26-030898) and the 10-Q periodic report (0001628280-26-031032) directly on SEC EDGAR. The filing index links above go to sec.gov.